Opendata, web and dolomites

Oximonitor

The first portable monitoring medical device providing accurate prognosis for patients with circulatory failure

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Oximonitor project word cloud

Explore the words cloud of the Oximonitor project. It provides you a very rough idea of what is the project "Oximonitor" about.

millions    decision    individuals    75    interpretation       company    societal    likewise    neonatal    enormous    proof    data    recover    sublingually    cloud    ip    staff    health    cells    worldwide    patented    count    back    surface    collecting    clinical    site    life    12    market    ecmo    cagr    learning    collects    oximonitor    respiratory    financial    care    poc    manner    34    patient    survivors    sent    point    400    heart    clab    2022    billion    specialists    patients    expand    costing    extracorporeal    inability    monitors    report    invasive    roi    22    function    sufficient    odi    sepsis    cumulative    exemplified    mlab    quantifying    first    computing    monitoring    dead    incorporates    2023    oxygenation    fingerprint    cardiac    35    start    viability    39    2017    creates    acute    software    platform    body    medical    accurately    o2    conjunctiva    17    skin    profit    clinically    predict    microcirculatory    circulatory    asphyxia    optical    symptom    effectiveness    dashboard    norwegian    machine    membrane    hardware    validated    bedside    generating    treatment   

Project "Oximonitor" data sheet

The following table provides information about the project.

Coordinator
ODI MEDICAL AS 

Organization address
address: OSLO SCIENCE PARK, GAUSTADALLEEN 21
city: OSLO
postcode: 349
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Norway [NO]
 Project website https://odimedical.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ODI MEDICAL AS NO (OSLO) coordinator 50˙000.00

Map

 Project objective

Microcirculatory failure (the inability to deliver sufficient O2 to the cells of the body), is a symptom from several health conditions affecting millions of individuals worldwide (e.g. heart failure, neonatal asphyxia or sepsis). The societal and financial impact of these conditions is enormous, as exemplified by patients in need of cardiac and respiratory support (such as extracorporeal membrane oxygenation life support or ECMO), with only 17% of survivors, while costing up to 1.35 M€ for a 1-year treatment. Specialists cannot predict if these patients are clinically dead or can recover because available medical devices do not allow to monitoring patient´s microcirculatory function. To solve this, at ODI Medical (a Norwegian start-up company) we have developed OXIMONITOR, the first-ever proof-of-concept validated, patented and non-invasive point of care (POC) integrated platform used bedside that accurately monitors microcirculatory function by quantifying O2 delivery and allows to assess the effectiveness of the patient´s treatment of choice, all in a user-friendly manner. OXIMONITOR incorporates: (1) The mLab hardware which creates an “optical fingerprint” of the patient’s circulatory function by collecting data from the surface of the patient’s skin, the conjunctiva or even sublingually. (2) The cLab; a Cloud computing software based on machine learning technology that collects and analyses the data generating the patient´s interpretation report, which is sent back to the clinical site through a user-friendly dashboard for decision-making. The market of cardiac monitoring (our first clinical application) will reach €22 billion by 2022 at a CAGR of 3.9% (2017-2022). With OXIMONITOR we will contribute to the viability of our company, generating a cumulative profit of 34.39 M€ (ROI of 12.75) and growing our staff count 400% by 2023. Likewise, the IP generated by this project will allow us to expand the number of clinical applications using our platform.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OXIMONITOR" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OXIMONITOR" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

ECOBIOMASS (2019)

Achieving unique wines through an efficient production process

Read More  

DetectInMen (2019)

Infection detection in human semen

Read More  

ALR4000 (2019)

Automated LCD Recycling series 4000

Read More